Genetic studies in mice and humans reveal new physiological roles for the high-density lipoprotein receptor scavenger receptor class B type I

被引:8
作者
Hoekstra, Menno [1 ]
Van Eck, Miranda [1 ]
Korporaal, Suzanne J. A. [1 ,2 ]
机构
[1] Gorlaeus Labs, Leiden Amsterdam Ctr Drug Res, Div Biopharmaceut, NL-2300 RA Leiden, Netherlands
[2] Univ Med Ctr Utrecht, Dept Clin Chem & Haematol, Utrecht, Netherlands
关键词
arterial thrombosis; HDL cholesterol; platelet function; scavenger receptor BI; steroidogenesis; ESTER TRANSFER PROTEIN; SR-BI; HDL CHOLESTEROL; TANGIER-DISEASE; TRANSPORTER A1; EXPRESSION; MUTATIONS; ATHEROSCLEROSIS; ALDOSTERONE; INHIBITION;
D O I
10.1097/MOL.0b013e3283508c09
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review Scavenger receptor class B type I (BI) is primarily known for its role in the selective uptake of cholesteryl esters from HDL, the final step in reverse cholesterol transport. Here, we will discuss findings that highlight the recently established novel link between scavenger receptor BI and adrenal and platelet function. Recent findings Human heterozygote carriers of a functional P297S mutation in the scavenger receptor BI gene show an attenuated adrenal glucocorticoid output and an altered platelet function. Scavenger receptor BI knockout mice lack adrenal cholesteryl ester stores and suffer from primary adrenal glucocorticoid insufficiency, indicating that adrenal HDL cholesteryl ester uptake by scavenger receptor BI is needed for generating the cholesterol pool used for steroidogenesis. Scavenger receptor BI knockout mice exhibit thrombocytopenia, an impaired platelet aggregation response, and higher susceptibility for arterial thrombosis. Bone marrow-specific deletion of scavenger receptor BI in mice indicates that scavenger receptor BI indirectly modulates platelet function through regulation of plasma cholesterol levels. Summary Scavenger receptor BI is not merely a crucial mediator of reverse cholesterol transport, but rather acts as a multipurpose player in cholesterol and steroid metabolism. Further understanding of the contribution of scavenger receptor BI's roles in adrenal steroidogenesis and platelet function to the pathogenesis of atherosclerosis and atherothrombosis will hopefully show its potential as a therapeutic target for cardiovascular benefit.
引用
收藏
页码:127 / 132
页数:6
相关论文
共 29 条
[1]  
[Anonymous], 2011, STAT AIM HIGH TRIAL
[2]   Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy [J].
Boden, William E. ;
Probstfield, Jeffrey L. ;
Anderson, Todd ;
Chaitman, Bernard R. ;
Desvignes-Nickens, Patrice ;
Koprowicz, Kent ;
McBride, Ruth ;
Teo, Koon ;
Weintraub, William .
NEW ENGLAND JOURNAL OF MEDICINE, 2011, 365 (24) :2255-2267
[3]   The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease [J].
Bodzioch, M ;
Orsó, E ;
Klucken, T ;
Langmann, T ;
Böttcher, L ;
Diederich, W ;
Drobnik, W ;
Barlage, S ;
Büchler, C ;
Porsch-Özcürümez, M ;
Kaminski, WE ;
Hahmann, HW ;
Oette, K ;
Rothe, G ;
Aslanidis, C ;
Lackner, KJ ;
Schmitz, G .
NATURE GENETICS, 1999, 22 (04) :347-351
[4]   Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI Role of negatively charged phospholipids [J].
Brodde, Martin F. ;
Korporaal, Suzanne J. A. ;
Herminghaus, Grazyna ;
Fobker, Manfred ;
Van Berkel, Theo J. C. ;
Tietge, Uwe J. F. ;
Robenek, Horst ;
Van Eck, Miranda ;
Kehrel, Beate E. ;
Nofer, Jerzy-Roch .
ATHEROSCLEROSIS, 2011, 215 (02) :374-382
[5]   Mutations in ABC1 in Tangier disease and familial high-density lipoprotein deficiency [J].
Brooks-Wilson, A ;
Marcil, M ;
Clee, SM ;
Zhang, LH ;
Roomp, K ;
van Dam, M ;
Yu, L ;
Brewer, C ;
Collins, JA ;
Molhuizen, HOF ;
Loubser, O ;
Ouelette, BFF ;
Fichter, K ;
Ashbourne-Excoffon, KJD ;
Sensen, CW ;
Scherer, S ;
Mott, S ;
Denis, M ;
Martindale, D ;
Frohlich, J ;
Morgan, K ;
Koop, B ;
Pimstone, S ;
Kastelein, JJP ;
Genest, J ;
Hayden, MR .
NATURE GENETICS, 1999, 22 (04) :336-345
[6]   Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans [J].
Brunham, L. R. ;
Tietjen, I. ;
Bochem, A. E. ;
Singaraja, R. R. ;
Franchini, P. L. ;
Radomski, C. ;
Mattice, M. ;
Legendre, A. ;
Hovingh, G. K. ;
Kastelein, J. J. P. ;
Hayden, M. R. .
CLINICAL GENETICS, 2011, 79 (06) :575-581
[7]   Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux [J].
Calkin, Anna C. ;
Drew, Brian G. ;
Ono, Akiko ;
Duffy, Stephen J. ;
Gordon, Michelle V. ;
Schoenwaelder, Simone M. ;
Sviridov, Dmitri ;
Cooper, Mark E. ;
Kingwell, Bronwyn A. ;
Jackson, Shaun P. .
CIRCULATION, 2009, 120 (21) :2095-U60
[8]   Evacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressure [J].
Cao, Guoqing ;
Beyer, Thomas P. ;
Zhang, Youyan ;
Schmidt, Robert J. ;
Chen, Yan Q. ;
Cockerham, Sandra L. ;
Zimmerman, Karen M. ;
Karathanasis, Sotirios K. ;
Cannady, Ellen A. ;
Fields, Todd ;
Mantlo, Nathan B. .
JOURNAL OF LIPID RESEARCH, 2011, 52 (12) :2169-2176
[9]   Thrombocytopenia and platelet abnormalities in high-density lipoprotein receptor-deficient mice [J].
Dole, Vandana S. ;
Matuskova, Jana ;
Vasile, Eliza ;
Yesilaltay, Ayce ;
Bergmeier, Wolfgang ;
Bernimoulin, Michael ;
Wagner, Denisa D. ;
Krieger, Monty .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2008, 28 (06) :1111-1116
[10]   Cholesteryl Ester Transfer Protein Expression Partially Attenuates the Adverse Effects of SR-BI Receptor Deficiency on Cholesterol Metabolism and Atherosclerosis [J].
El Bouhassani, Majda ;
Gilibert, Sophie ;
Moreau, Martine ;
Saint-Charles, Flora ;
Treguier, Morgan ;
Poti, Francesco ;
Chapman, M. John ;
Le Goff, Wilfried ;
Lesnik, Philippe ;
Huby, Thierry .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2011, 286 (19) :17227-17238